menu search

Reneo pharmaceuticals: buy before upcoming pivotal data drop

Reneo Pharmaceuticals is developing mitochondrial disease therapies, with its lead program being mavode...

October 29, 2023, 8:00 pm

Reneo pharmaceuticals announces poster presentation at upcoming scientific meetings

IRVINE, Calif., Oct. 25, 2023 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the ...

October 25, 2023, 11:50 am

Clene to present at upcoming september conferences

SALT LAKE CITY, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary...

August 30, 2023, 8:20 am

Reneo pharmaceuticals to participate in upcoming investor conferences

IRVINE, Calif., Aug. 29, 2023 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the ...

August 29, 2023, 11:35 am

Reneo pharmaceuticals to participate in svb securities therapeutics forum

IRVINE, Calif., June 30, 2023 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the ...

June 30, 2023, 12:25 pm

Genedx to present new data on urine mitochondrial dna testing at the 2023 united mitochondrial disease foundation’s mitochondrial medicine symposium

STAMFORD, Conn., June 28, 2023 (GLOBE NEWSWIRE) — GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical...

June 28, 2023, 11:00 am

Reneo pharmaceuticals added to russell 2000® and russell 3000® indices

IRVINE, Calif., June 26, 2023 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical-stage pharmaceutical company focused on the ...

June 26, 2023, 12:25 pm

Update — reneo pharmaceuticals to participate at the jefferies healthcare conference

IRVINE, Calif., May 31, 2023 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the d...

May 31, 2023, 2:38 pm

Cyclerion announces definitive agreement for zagociguat and cy3018

Certain Cyclerion shareholders and new investors have agreed to invest $81M to launch a new company targeting diseases of ...

May 11, 2023, 10:00 pm

Reneo announces pricing of public offering of common stock

IRVINE, Calif., May 03, 2023 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (Reneo) (Nasdaq: RPHM), a clinical-stage pharmaceutical company focused ...

May 4, 2023, 3:36 am

Reneo pharmaceuticals to participate in svb securities global biopharma conference

IRVINE, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the ...

February 2, 2023, 12:35 pm

Mayflower bioventures launches its first spin-out, primera therapeutics, in strategic collaboration with cellectis to develop a gene editing platform to treat mitochondrial diseases

NEW YORK, Dec. 29, 2022 (GLOBE NEWSWIRE) — Following the formation of Mayflower Bioventures, a cell and gene therapy accelerator stood up from Hibis...

December 29, 2022, 9:30 pm

Unicycive to participate in upcoming investor conferences

Highlights Late-Stage Program in Hyperphosphatemia and Early-Stage Program to Combat Diseases of mitochondrial...

November 28, 2022, 7:00 am

Reneo pharmaceuticals to participate at upcoming investor conferences

IRVINE, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the ...

September 6, 2022, 8:35 am


Search within

Pages Search Results: